What does GRAIL, Inc. do?
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic…
What is GRAIL, Inc.'s P/E and P/B ratio?
GRAIL, Inc. has a P/E ratio of -13.1 and a P/B ratio of 2.23.
What is GRAIL, Inc.'s debt-to-equity ratio?
GRAIL, Inc. has a debt-to-equity ratio of 0.04.
How much does GRAIL, Inc. owe compared with what it owns?
GRAIL, Inc. owes $0.11 for every $1 it owns (balance sheet Jun 2026), which is low.
What is GRAIL, Inc.'s Positivity rank?
GRAIL, Inc. is ranked #4,640 of 6,775 companies globally and #2,362 of 4,000 in United States on PositoAI, with a Positivity Score of 19,211.
Does GRAIL, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for GRAIL, Inc..
Where can I read the latest news about GRAIL, Inc.?
Recent headlines about GRAIL, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does GRAIL, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of GRAIL, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.